When consumers think about toothpaste for sensitive teeth, Sensodyne is one of the most recognizable names. But who owns Sensodyne, and where does the brand fit within the rapidly expanding global oral-care industry?

Sensodyne is owned by Haleon plc, a global consumer-healthcare company. Haleon’s oral-health portfolio also includes Parodontax, Polident, and Corsodyl, giving the company exposure across sensitivity, gum health, denture care, and other oral-health needs. Towards Healthcare identifies Haleon as a Tier 1 company in the global oral-care competitive landscape, with Sensodyne among its key brands.

Sensodyne at a Glance

Brand: Sensodyne
Owner: Haleon plc
Primary focus: Tooth sensitivity and specialized oral care
Parent company headquarters: Weybridge, United Kingdom
Broader portfolio: Sensodyne, Parodontax, Polident, Corsodyl

The ownership is important because Sensodyne is not operating as an independent oral-care company. It is part of Haleon’s broader consumer-health strategy, giving the brand access to global distribution, product development, and a diversified oral-health portfolio.

The Global Oral Care Industry Is Getting Bigger

The opportunity behind Sensodyne extends well beyond sensitive-teeth toothpaste.

According to Towards Healthcare, the global oral care market is projected to grow from USD 46.21 billion in 2026 to USD 83.12 billion by 2035, representing a 6.74% CAGR. The market was estimated at USD 43.29 billion in 2025.

Access Our Research Insights:  https://www.towardshealthcare.com/download-sample/5269

This growth is being supported by increasing awareness of preventive oral health, rising demand for specialized products, premium oral-care solutions, e-commerce adoption, and product innovation.

Key Towards Healthcare statistics

• 2025 market size: USD 43.29 billion
• 2026 market size: USD 46.21 billion
• 2035 projected size: USD 83.12 billion
• 2026–2035 CAGR: 6.74%
• Asia-Pacific share in 2025: 44%
• Toothbrush segment share in 2025: 40%
• Supermarkets/hypermarkets share in 2025: 45%

These figures show why global companies such as Haleon continue to invest in oral-health innovation and distribution.

Why Sensodyne Has a Strong Position

Sensodyne is built around a specific consumer problem: tooth sensitivity.

Rather than competing only as a general-purpose toothpaste brand, Sensodyne has developed a more specialized proposition around sensitivity protection.

This is strategically valuable in a market where consumers are increasingly looking for products designed for particular oral-health concerns.

Towards Healthcare’s analysis shows that the global oral-care ecosystem now extends across daily oral hygiene, cavity prevention, gum disease management, teeth whitening, denture care, breath freshening, and preventive dental care.

Sensodyne therefore occupies an important specialized position within the wider category.

Haleon vs. Other Major Oral-Care Companies

Haleon competes with several major global companies across oral care.

Haleon vs. Colgate-Palmolive: Colgate-Palmolive has one of the broadest oral-care portfolios and strong worldwide distribution, while Haleon has a particularly strong position in specialized therapeutic oral care through brands such as Sensodyne and Parodontax. Towards Healthcare places both companies among the leading Tier 1 participants.

Haleon vs. Procter & Gamble: P&G competes through brands including Oral-B and Crest, with strength across toothpaste, toothbrushes, and electric oral-care products. Haleon, meanwhile, has a stronger emphasis on consumer-health and therapeutic oral-care categories.

Haleon vs. Unilever: Unilever participates in oral care through brands such as Signal and Closeup in selected markets, while Haleon has a more concentrated consumer-health portfolio spanning sensitivity, gum health, and denture care.

This makes the competitive landscape less about one company dominating every category and more about different companies leading different oral-health needs.

Asia-Pacific Is the Largest Regional Opportunity

One of the most interesting findings from Towards Healthcare is the strength of Asia-Pacific.

The region accounted for approximately 44% of the global oral-care market in 2025, making it the largest regional market.

The region’s growth is being supported by:

• Increasing oral-health awareness
• Growing consumer healthcare spending
• Rising dental disease burden
• Government initiatives
• Urbanization
• Premium oral-care adoption
• Expansion of online retail

For companies such as Haleon, this creates a significant opportunity to expand specialized products such as Sensodyne across emerging and developed Asian markets.

Online Retail Is Changing How Consumers Buy Oral Care

Consumers no longer need to purchase toothpaste and other oral-care products exclusively from physical stores.

Towards Healthcare identifies online retail as the fastest-growing distribution channel in the global oral-care market. Meanwhile, supermarkets and hypermarkets represented approximately 45% of the market in 2025.

This creates an increasingly omnichannel environment:

Supermarkets → Pharmacies → Dental clinics → E-commerce → Direct-to-consumer

For established brands like Sensodyne, strong physical distribution combined with digital visibility can help reach consumers searching specifically for sensitivity-related solutions.

Sensodyne Is Part of a Larger Haleon Oral-Health Strategy

One reason Haleon’s position is interesting is the breadth of its oral-care portfolio.

• Sensodyne focuses on sensitivity.
• Parodontax focuses on gum health.
• Polident addresses denture care.
• Corsodyl serves specialized oral-health needs.

Towards Healthcare’s competitive assessment identifies Haleon plc as a Tier 1 participant in the global oral-care market and specifically lists Sensodyne, Parodontax, and Polident among its key products.

This diversified portfolio allows Haleon to address multiple stages and needs within oral health rather than relying on one toothpaste category.

Why the Opportunity Goes Beyond Toothpaste

The oral-care ecosystem is becoming increasingly diversified.

Towards Healthcare estimates that the global oral-rinses market was USD 4.12 billion in 2024, reached approximately USD 4.39 billion in 2025, and is projected to reach USD 7.7 billion by 2034, growing at a 6.46% CAGR.

Sensodyne itself expanded beyond toothpaste with Sensodyne Complete Protection+ Mouthwash, demonstrating how established brands are extending into adjacent oral-care categories.

This is an important industry trend: consumers increasingly expect complete oral-care routines rather than a single product.

What Does This Mean for the Future of Sensodyne?

The broader market outlook is favorable.

With the global oral-care market expected to reach USD 83.12 billion by 2035, companies with strong brands, specialized formulations, global distribution, and consumer trust are well positioned to benefit from category expansion.

Sensodyne’s specialized positioning gives Haleon an opportunity to participate in several major trends:

Specialized oral care → Preventive health → Premium products → E-commerce → Personalized consumer needs

The growing focus on preventive healthcare also fits naturally with consumer-health products that people can use as part of their daily routines.

Expert View by Payal Rabde – highlighting the trends shaping the future of healthcare.

Get smarter healthcare insights with our dedicated Ecosystem Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Pharma Geek is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.

You can place an order or ask any questions, please feel free to contact us at [email protected]

Europe Region – +44 778 256 0738

North America Region – +1 8044 4193 44

APAC Region: +91 9356 9282 04

Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium